Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 112.47%8.69M | 181.05%3.04M | 140.79%2.94M | 23.39%1.44M | 104.19%1.27M | 99.66%4.09M | 106.49%1.08M | 114.96%1.22M | 108.02%1.17M | 56.57%620K |
Operating revenue | 108.89%8.37M | 172.04%2.92M | 139.62%2.79M | 22.51%1.4M | 106.11%1.25M | 112.81%4.01M | 119.43%1.07M | 122.94%1.17M | 119.12%1.15M | 74.14%606K |
Cost of revenue | 59.89%5.94M | 93.50%2.26M | 89.05%1.66M | 3.83%1.03M | 46.09%989K | 107.31%3.72M | 139.55%1.17M | 108.81%877K | 115.65%992K | 61.96%677K |
Gross profit | 634.76%2.75M | 995.40%779K | 272.67%1.28M | 134.29%410K | 585.96%277K | 46.09%374K | -341.67%-87K | 132.43%344K | 73.27%175K | -159.09%-57K |
Operating expense | 63.65%6.3M | 43.11%1.62M | 116.53%2.07M | 56.24%1.46M | 38.98%1.15M | 6.85%3.85M | 38.56%1.13M | -19.32%956K | 14.41%937K | 4.56%826K |
Selling and administrative expenses | 73.96%5.91M | 57.44%1.54M | 124.52%2.01M | 63.64%1.31M | 42.26%1.06M | 20.67%3.4M | 38.89%975K | 23.34%893K | 22.97%803K | 4.65%743K |
-Selling and marketing expense | 404.55%2.22M | 26,250.00%527K | 460.11%997K | 166.27%442K | 169.15%253K | 0.92%440K | -97.75%2K | 72.82%178K | 107.50%166K | 141.03%94K |
-General and administrative expense | 24.78%3.69M | 3.60%1.01M | 40.98%1.01M | 36.89%872K | 23.88%804K | 24.29%2.96M | 58.73%973K | 15.14%715K | 11.17%637K | -3.28%649K |
Research and development costs | -24.27%78K | --0 | --0 | 38.18%76K | -93.10%2K | -71.93%103K | -66.67%13K | -96.89%6K | -50.45%55K | 20.83%29K |
Depreciation amortization depletion | 23.81%156K | -51.06%46K | 440.00%27K | 225.00%52K | 210.00%31K | 687.50%126K | 1,780.00%94K | 25.00%5K | 128.57%16K | 42.86%10K |
-Depreciation and amortization | 23.81%156K | -51.06%46K | 440.00%27K | 225.00%52K | 210.00%31K | 687.50%126K | 1,780.00%94K | 25.00%5K | 128.57%16K | 42.86%10K |
Other taxes | -29.91%157K | -22.00%39K | -26.92%38K | -65.08%22K | 31.82%58K | -44.69%224K | -29.58%50K | -80.30%52K | 31.25%63K | -10.20%44K |
Operating profit | -2.21%-3.55M | 31.01%-841K | -28.76%-788K | -38.32%-1.05M | 1.36%-871K | -3.85%-3.48M | -56.08%-1.22M | 40.98%-612K | -6.13%-762K | -8.74%-883K |
Net non-operating interest income expense | -440.00%-81K | -220.00%-16K | -900.00%-20K | -314.29%-29K | -1,400.00%-15K | 98.88%-15K | -150.00%-5K | 99.17%-2K | 97.99%-7K | 99.87%-1K |
Non-operating interest income | ---- | ---- | --0 | -50.00%1K | ---- | ---- | ---- | --1K | --2K | ---- |
Non-operating interest expense | 440.00%81K | 600.00%14K | 566.67%20K | 233.33%30K | 1,400.00%15K | -98.88%15K | 0.00%2K | -98.76%3K | -97.41%9K | -99.87%1K |
Other net income (expense) | -43.42%172K | -10.81%33K | -12.90%54K | -18.11%104K | -124.68%-19K | 590.32%304K | -72.59%37K | 19.23%62K | 309.68%127K | 127.50%77K |
Gain on sale of security | -66.55%96K | -113.04%-3K | -75.81%15K | -19.69%102K | -126.03%-19K | 237.65%287K | -82.84%23K | 19.23%62K | 337.93%127K | 156.15%73K |
Special income (charges) | ---18K | ---- | ---- | ---4K | ---- | --0 | ---- | ---- | --0 | ---- |
-Less:Restructuring and merger&acquisition | --18K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---4K | ---- | ---- | ---- | ---- | --0 | ---- |
Other non- operating income (expenses) | 452.94%94K | 285.71%54K | --39K | --6K | ---- | 466.67%17K | 1,300.00%14K | ---- | ---- | --4K |
Income before tax | -8.63%-3.46M | 30.58%-824K | -36.59%-754K | -52.49%-979K | -12.14%-905K | 32.83%-3.19M | -83.18%-1.19M | 55.01%-552K | 37.97%-642K | 56.05%-807K |
Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income | -8.63%-3.46M | 30.58%-824K | -36.59%-754K | -52.49%-979K | -12.14%-905K | 32.83%-3.19M | -83.18%-1.19M | 55.01%-552K | 37.97%-642K | 56.05%-807K |
Net income continuous Operations | -8.63%-3.46M | 30.58%-824K | -36.59%-754K | -52.49%-979K | -12.14%-905K | 32.83%-3.19M | -83.18%-1.19M | 55.01%-552K | 37.97%-642K | 56.05%-807K |
Minority interest income | -487.10%-182K | 129.21%26K | -2,950.00%-61K | -277.36%-94K | -842.86%-52K | -31K | -89K | -2K | 53K | 7K |
Net income attributable to the parent company | -3.93%-3.28M | 22.59%-850K | -26.00%-693K | -27.34%-885K | -4.79%-853K | 33.48%-3.16M | -69.44%-1.1M | 55.18%-550K | 32.85%-695K | 55.66%-814K |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -3.93%-3.28M | 22.59%-850K | -26.00%-693K | -27.34%-885K | -4.79%-853K | 33.48%-3.16M | -69.44%-1.1M | 55.18%-550K | 32.85%-695K | 55.66%-814K |
Basic earnings per share | 10.71%-0.5 | 45.00%-0.11 | -10.00%-0.11 | -16.67%-0.14 | 6.67%-0.14 | 34.12%-0.56 | -81.82%-0.2 | 54.55%-0.1 | 36.84%-0.12 | 54.55%-0.15 |
Diluted earnings per share | 10.71%-0.5 | 45.00%-0.11 | -10.00%-0.11 | -16.67%-0.14 | 6.67%-0.14 | 34.12%-0.56 | -81.82%-0.2 | 54.55%-0.1 | 36.84%-0.12 | 54.55%-0.15 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |